D-0357-2025 Class II Ongoing
FDA drug recall D-0357-2025 was initiated by Somerset Therapeutics Private Limited on Mar 21, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Media fill with bacterial contamination The recall status is ongoing. Affected quantity: 23,960 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 16, 2025
- Initiation Date
- Mar 21, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,960 vials
Product description
Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons)
Reason for recall
Lack of Assurance of Sterility: Media fill with bacterial contamination
Distribution pattern
U.S. Nationwide
Code information
NDC 68001-581-41; A240482A, exp. date 08/2026; NDC 68001-581-48; A240482B, exp. date 08/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0357-2025
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026